Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Gradishar WJ, Anderson BO, Balassanian R et al (2017) NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Canc Netw 15(4):433–451
2. Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J ClinOncol 35(5):561–564
3. Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F (2009) Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250(4):558–566
4. El HageChehade H, Headon H, Kasem A, Mokbel K (2016) Refining the performance of sentinel lymph node biopsy post-neoadjuvant chemotherapy in patients with pathologically proven pre-treatment node-positive breast cancer: an update for clinical practice. Anticancer Res 36(4):1461–1471
5. Hennessy BT, Hortobagyi GN, Rouzier R et al (2005) Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J ClinOncol 23(36):9304–9311